Join us in August to:

• Interrogate the common understanding of genetics, pathophysiology and drug mechanisms of action to identify new targets and opportunities to develop more clinically effective therapeutic
• Approach translational roadblocks differently to capitalize on the latest in vitro innovations and more confidently fast track into the clinic
• Dissect definitions of progressive fibrosis interstitial lung diseases and understand the mechanisms of cross-organ pathological fibrosis to inform your future anti-fibrotic strategy